What Is the Prognosis of Chronic Myelogenous Leukemia?

  • 1

1 Answer

These messages are for mutual support and information sharing only. Always consult your doctor before trying anything you read here.
Chronic myelogenous leukemia (CML) is a type of cancer that has relatively positive prognosis. According to the National Cancer Institute, the overall 5-year survival rate of the patients with CML is 65.1%. In the process of improving the 5-year survival rate, the creation of tyrosine kinase inhibitors contributes tremendously. In 2006, in the test to determine the effect of imatinib (Gleevec), the 5-year survival rate increased to 89%. Besides, other new drugs are being developed, which is much likely to improve survival rates in the future.   Keywords: chronic myeloid leukemia prognosis; prognosis chronic myeloid leukemia
I was diagnosed with CML in September of 2007. I was immediately placed on Gleevec. It's been just over12 years. My body is now resistant to the medication. I'll be starting on Sprycel soon. Hopefully it'll give me at least another 12 years. I'm thankful for the Gleevec and for the 12 years it's given me so far.
Becky surprised they suggested Sprycel, had some side affects with that - I’m on Tasigna which seems much more tolerable - only drawback is having to take twice a day